APA-viite

Balakrishnan, B., An, D., Nguyen, V., DeAntonis, C., Martini, P. G., & Lai, K. (2020). Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia. Mol Ther.

Chicago-tyylinen lähdeviittaus

Balakrishnan, Bijina, Ding An, Vi Nguyen, Christine DeAntonis, Paolo G.V Martini, ja Kent Lai. "Novel MRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia." Mol Ther 2020.

MLA-viite

Balakrishnan, Bijina, et al. "Novel MRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia." Mol Ther 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.